8-K
Current Report
Transcode Therapeutics, Inc. Filed Acc 0001104659-26-040171
Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- Item 3.02 Unregistered sales of equity securities
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading tm2611272d1_8k.htm…